关于
  • English
  • About
    • About Sirona
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
  • TFChem
    • About TFChem
    • Management
    • Team
    • TFChem Laboratory Capabilities
  • Programs
    • Proprietary Platform Technology
    • Pipeline
    • Diabetes – SGLT2 Inhibitor
    • Skincare – Dark Spot Correction
    • Skincare – Anti-Aging / Anti-Wrinkle
    • Antiviral
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
  • Contact
  • Careers

October 13th, 2016

Sirona Biochem to attend Cosmetic 360, Paris FranceOctober 13-14, 2016

September 15th, 2016

Sirona Annual General Meeting605-889 West Pender StVancouver BCWednesday, September 21st, 2016

July 29th, 2016

Sirona Biochem to present at IMCAS AsiaJuly 29-31, 2016View Abstract

June 30th, 2016

Sirona Biochem CEO’s Report on Progress

June 13th, 2016

Sirona Biochem Announces Wanbang Biopharmaceuticals to Proceed to Pre-IND Testing and Receipt of $300,000 USD Milestone Payment

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 43
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading